Kathryn Aron, Ph.D.Group Leader, Cell Culture Process Development at Bristol-Myers Squibb
Dr. Aron has over 10 years of experience in Upstream Process Development, first at Cook Pharmica in Bloomington, IN, and then at Bristol-Myers Squibb in Devens, MA. In more than 6 years at BMS she has taken a leading role in the development, transfer, and characterization of multiple drug substance processes. Meanwhile, she has developed an expertise in raw materials, leading a number of materials-related cross-functional initiatives and studies. Dr. Aron received her Ph.D. in Biochemistry and Molecular Pharmacology from Harvard Medical School, followed by post-doctoral work at Wyeth in Cambridge, MA.